Cargando…
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
Clear cell (cc) renal cell carcinoma (RCC) is the most common type of cancer found in the kidney accounting for ~90% of all kidney cancers. In 2012, there were ~337,000 new cases of RCC diagnosed worldwide with an estimated 143,000 deaths, with the highest incidence and mortality in Western countrie...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045229/ https://www.ncbi.nlm.nih.gov/pubmed/27713636 http://dx.doi.org/10.2147/OTT.S97397 |